Progressive Care Inc. Announces April Sales & Record Breaking
Month
MIAMI
– May 21, 2019 -- InvestorsHub NewsWire -- Progressive
Care Inc. (OTCQB:
RXMD),
a personalized healthcare services and technology company, today
announced further growth year-over-year in revenue and number of
prescriptions filled for April 2019 and a record month for
PharmCo
revenue
in Palm Beach,
which increased
at 100%.
In
April, the company reported a total of $1.935 million in net
revenue, a 17% increase from the same month last year, and a 30%
increase in prescriptions filled during the same month last year,
totaling nearly 28,725 prescriptions filled. Both
PharmCo
locations
had 15% growth in prescription counts compared to April last
year.
"Progressive
Care's April sales and prescription numbers are directly attributed
to increased sales derived from marketing activities promoting risk
management, medication adherence management, and superior pharmacy
performance metrics to Physicians Practices and Management
Services Organizations,"
said S. Parikh Mars, Chief Executive Officer of Progressive Care
Inc. "We are confident that our company will continue to grow with
more record-breaking months by providing our customers with
top-quality healthcare management services."
For
more information about Progressive Care, please visit the
company's website.
Connect and stay
in touch with us on social media:
Progressive
Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About
Progressive Care Inc.
Progressive Care
Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida
health services organization and provider of prescription
pharmaceuticals, compounded medications, provider of tele-pharmacy
services, the sale of anti-retroviral medications, medication
therapy management (MTM), the supply of prescription medications to
long-term care facilities, and health practice risk
management.
Cautionary Statement Regarding Forward-Looking Statements
Statements
contained herein that are not based upon current or historical fact
are forward-looking in nature and constitute forward-looking
statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Such forward-looking statements
reflect the Company's expectations about its future operating
results, performance, and opportunities that involve substantial
risks and uncertainties. These statements include but are not
limited to statements regarding the intended terms of the offering,
closing of the offering and use of any proceeds from the offering.
When used herein, the words "anticipate," "believe," "estimate,"
"upcoming," "plan," "target," "intend" and "expect" and similar
expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number
of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Investor
Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public
Relations Contact:
Kathleen
Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and
Application Development Contact:
Marcello Jaspan,
Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com